Quick Takeaways
- ARMISTICE CAPITAL, LLC filed SCHEDULE 13G for BELLICUM PHARMACEUTICALS INC Common Stock (BITF).
- Disclosed ownership: 10%.
- Date of event: 30 Jun 2025.
ARMISTICE CAPITAL, LLC - 30 Jun 2025 SCHEDULE 13G Report for BELLICUM PHARMACEUTICALS INC Common Stock (BITF)
- Filing Manager
- ARMISTICE CAPITAL, LLC
- Reporting Manager
- Armistice Capital, LLC
- Symbol
- BITF
- Shares outstanding
- 10,795,385 shares
- Disclosed Ownership
- 1,078,459 shares
- Ownership
- 10%
- Form type
- SCHEDULE 13G
- Filing time
- 14 Aug 2025, 20:53:34 UTC
- Date of event
- 30 Jun 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"ARMISTICE CAPITAL, LLC disclosed 10% ownership in BELLICUM PHARMACEUTICALS INC Common Stock (BITF) on 30 Jun 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Aug 2025, 20:53.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Armistice Capital, LLC | 10% | 1,078,459 | 0 | 1,078,459 | /s/ Steven Boyd | Steven Boyd - Managing Member | |
| Steven Boyd | 10% | 492,232 | 0 | 1,078,459 | /s/ Steven Boyd | Steven Boyd |